McCarthy Cornelius P. III sold $690K of MEDP
McCarthy Cornelius P. III sold 1,140 shares of Medpace Holdings, Inc. (MEDP) at $605.37 ($0.69M total) on 2026-08-11.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale details (shares, price, total value, and post-transaction holdings). There is no new operational, financial, or regulatory information about Medpace.
Market read
Traders may briefly monitor insider activity, but this specific disclosure does not change Medpace’s fundamentals based on the provided text.
What to watch
Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context, the signal-to-noise is low.
Background
The article is an SEC Form 4 insider transaction disclosure for Medpace Holdings, Inc. (MEDP).
Ticker impact
Medpace director McCarthy sold 1,140 shares in an open-market transaction at $605.37 on 2026-08-11, per Form 4 filed 2026-08-13.
Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.
The filing is a Form 4 insider transaction. The article provides transaction size, price, and post-sale holdings, but no accompanying company news, earnings, or operational update.
Market effects
Minimal. Insider sales typically do not reset sector expectations without accompanying company-specific news.
None indicated.
None indicated.
Counterpoint
Because the filing states no pre-arranged 10b5-1 plan, some traders may interpret the sale as a stronger signal than a typical planned transaction, even though the article lacks context.
Key entities
- issuerMedpace Holdings, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderMcCarthy Cornelius P. III
Director who sold 1,140 shares at $605.37 per share.